scholarly journals Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Regimen in the Treatment of Genotype 1 Chronic Hepatitis C Infection in Patients with Severe Renal Impairment and End-Stage Renal Disease: a Real-Life Cohort

2018 ◽  
Vol 43 (2) ◽  
pp. 594-605 ◽  
Author(s):  
Jan Sperl ◽  
Miluse Kreidlova ◽  
Dusan Merta ◽  
Klara Chmelova ◽  
Renata Senkerikova ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Renal Impairment ◽  
End Stage Renal Disease ◽  
Severe Renal Impairment ◽  
Real Life ◽  
Genotype 1 ◽  
Hepatitis C Infection ◽  
Stage Renal Disease ◽  
End Stage

Sofosbuvir-based treatment is safe and effective in patients with chronic hepatitis C infection and end stage renal disease: a case series

2016 ◽  
Vol 36 (6) ◽  
pp. 802-806 ◽  
Author(s):  
Tavankit Singh ◽  
John Guirguis ◽  
Sumi Anthony ◽  
John Rivas ◽  
Ibrahim A. Hanouneh ◽  
...  
Keyword(s):  
Chronic Hepatitis ◽  
Hepatitis C ◽  
Renal Disease ◽  
Chronic Hepatitis C ◽  
End Stage Renal Disease ◽  
Case Series ◽  
Hepatitis C Infection ◽  
Stage Renal Disease ◽  
End Stage
Sign in / Sign up

Export Citation Format

Share Document